Bangkok, The Comptroller General's Department has added a list of injections for high blood fats. Increase access to medicine necessary and effective for treatment Mrs. Patricia Mongkhonvanich, Director-General of the Comptroller General's Department, revealed that the Comptroller General's Department has joined with the Thai Heart Association. under royal patronage Kidney Association of Thailand and the Endocrine Society of Thailand Set guidelines for regulating the disbursement of injection medicine costs. For patients with hyperlipidemia who use their rights to medical benefits for civil servants By adding one more item to the list of new injectable medicines registered with the FDA after January 1, 2018, from the original 2 items patients were able to withdraw, making it currently difficult for patients with hyperlipidemia. Can access 3 medicines for such treatment, with reimbursement rates as follows: Evolocumab medicine costs 5,000 baht per injection. Alirocumab medicine costs 5,000 baht per injectio n. Inclisiran medicine costs 50,000 baht per injection. Director General of the Comptroller General's Department Added that for those with rights and family members Have access to necessary and effective medicines Under appropriate circumstances and consistent with the budget burden Asked for cooperation from health care facilities in using such injectable drugs in accordance with the established guidelines for drug reimbursement. No excess expenses will be collected from patients. This will be effective for medical expenses incurred from 1 March 2024 onwards. If you have any questions, you can contact and inquire at the Medical Welfare Division, Comptroller General's Department. Telephone number 0 2127 7000 ext. 6850 during business days and hours. Source: Thai News Agency